Latest Episodes

Leaders in science join us to bring you valuable insights into the world of biotechnology. Subscribe and never miss an episode.

Latest Episodes

Bryan Dechairo - Sherlock Biosciences - Part 2

Transitioning From a Small Startup to Pfizer | Big Data's Role in Modern Genetics | Building & Leading Dynamic Teams | The Evolution of Personalized Medicine

Bryan Dechairo - Sherlock Biosciences - Part 1

A Love of Science Blossoming from a 10-Acre Hobby Farm | Experiencing Great Diversity at UC Berkeley | Growth & Enjoyment of Startups | Unexpected Travels to Pursue a Dream Overseas

Terry Lo - Vizgen - Part 3

Transitioning to Vizgen | What is Spatial Genomics | Importance of Genetic Mapping | How to Grow Your Company During Turbulent Times

Terry Lo - Vizgen - Part 2

Terry’s Move from Big Pharma to Diagnostics | Introduction to Spatial Biology | Navigating Regulatory & Reimbursement Challenges in Diagnostics | Balancing Multiple Roles in M&A Negotiations

Terry Lo - Vizgen - Part 1

Leveraging a Passion for Science to Succeed in Finance | Sales Excellence as an Introvert Through Competition | Financial Modeling & Creating Proper Deal Structure | How Not To Be A Jack of All Trades

Mike Stadnisky - Thielsen Capital - Part 3

Don’t Fake it ‘Til you Make It | Cleaning Your Corporate “Underwear” | Thielsen’s Investment Philosophy | The Critical Importance of Alignment

Mike Stadnisky - Thielsen Capital - Part 2

Transitioning from Lab Bench to Industry | Breaking Into Business Development | Finding Decision Makers & Champions | Navigating Partnerships & Strategy

Mike Stadnisky - Thielsen Capital - Part 1

Familial Exposure to Business & Science at a Young Age | The Importance of “Care Before You Share” | Actively Managing Your Time | A PhD is a 10,000 Hour Degree

Martin Brenner - iBio - Part 3

Transitioning from Big Pharma to Biotech Startups | Lessons in Flexibility, Resilience, & Adaptability | Challenging Long-Held Beliefs in Drug Discovery | The Evolution & Future of iBio

Martin Brenner - iBio - Part 2

Autonomy at Eli Lilly vs. Structure at Pfizer | Transitioning from AstraZeneca to Merck | Joys & Challenges When Relocating for Work | A Biotech Vision Leading to an Exit From Big Pharma

Martin Brenner - iBio - Part 1

How Childhood Influences Shape Career Paths | Unexpected Crossovers Between Engineering & Veterinary Clinics | Eli Lilly Nurturing His Professional Development | Communication Can Make or Break Leadership

Jeff Kim - Slingshot Biosciences - Part 3

Bucking the Status Quo | Raising Capital During Peak COVID | How To Find & Retain Great Talent | Building Partnerships with Distributors